Adcock Ingram, which counts Panado painkillers and the cold and flu product Corenza C among its brands, says an improvement in demand for over-the-counter products and innovative marketing helped it grow trading profit by a quarter in its half year to end-December.
New products, such as additional Panado variants, helped boost Adcock’s consumer business to well above pre-pandemic levels, CEO Andy Hall told Business Day, with the group pleased by improved margins and about R200m in revenue from products that weren’t in the market a year ago...
Source: News Formal (newsformal.com)
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Adcock Ingram gets profit bump as OTC drug demand picks upSA’s cold and flu season was largely absent in 2020, but the company says improved demand and innovative marketing helped it in 2021
Source: BDliveSA - 🏆 12. / 63 Read more »
Adcock Ingram gets profit bump as OTC drug demand picks upSA’s cold and flu season was largely absent in 2020, but the company says improved demand and innovative marketing helped it in 2021
Source: BDliveSA - 🏆 12. / 63 Read more »
Super Group gets boost from New Zealand acquisitionTransport group’s core profit rises by half in half-year to end-December
Source: BDliveSA - 🏆 12. / 63 Read more »
NEWS FROM THE FUTURE: Microchips save the American dreamAmid soaring global demand for chips companies like Nvidia have risen to the challenge
Source: BDliveSA - 🏆 12. / 63 Read more »
NEWS FROM THE FUTURE: Microchips save the American dreamAmid soaring global demand for chips companies like Nvidia have risen to the challenge Couple of months ago I came across a recommendation about Arnoldnike93 wealth how he helped investors to earn lots of money with their investments. and I decided to give a trial with the little I have. Now my little has turned into something great which was not my expectation
Source: BDliveSA - 🏆 12. / 63 Read more »
AstraZeneca’s oncology credentials boost its big pharma statusNew drug made with Japanese unit scores a blow in battle against breast cancer
Source: BDliveSA - 🏆 12. / 63 Read more »